ORAL RIGOSERTIB COMBINED WITH AZACITIDINE IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROMES (MDS): EFFECTS IN TREATMENT NAIVE AND RELAPSED/REFRACTORY PATIENTS

被引：0
|
作者：
Navada, S. [1 ]
Garcia-Manero, G. [2 ]
Hearn, K. [2 ]
Odchimar-Reissig, R. [1 ]
Demakos, E. [1 ]
Fenaux, P. [3 ]
Petrone, M. [4 ]
Zbyszewski, P. [4 ]
Fruchtman, S. [4 ]
Silverman, L. [1 ]
机构：
[1] Icahn Sch Med Mt Sinai, Tisch Canc Inst, New York, NY 10029 USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[3] Hop St Louis Univ, Paris, France
[4] Onconova Therapeut, Newtown, PA USA
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
S488
引用
收藏
页码：183 / 184
页数：2
相关论文
共 50 条
  • [41] REDIFINING MONOSOMY 20 BY MOLECULAR CYTOGENETICS IN 1.0 MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIA (MDS/AML) PATIENTS
    Bernasconi, P.
    Dambruoso, I.
    Boni, M.
    Zappatore, R.
    Cavigliano, P. M.
    Giardini, I.
    Calatroni, S.
    Rocca, B.
    Caresana, M.
    Tarantino, P.
    Lazzarino, M.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 273 - 273
  • [42] Low dose Vidaza and thalidomide is an effective combination for patients with myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML).
    Westervelt, P.
    Amirifeli, S.
    Mehdi, M.
    Mumtaz, M.
    Alhomsi, S.
    Wang, S.
    Miron, P.
    Lata, C.
    Galili, N.
    Raza, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 354S - 354S
  • [43] Azacitidine in Patients with Relapsed/Refractory Acute Myeloid Leukemia : Retrospective Analysis of the Austrian Azacitidine Registry
    Pleyer, Lisa
    Burgstaller, Sonja
    Stauder, Reinhard
    Girschikofsky, Michael
    Linkesch, Werner
    Pfeilstoecker, Michael
    Autzinger, Eva Maria
    Tinchon, Christoph
    Sliwa, Thamer
    Lang, Alois
    Sperr, Wolfgang R.
    Geissler, Dietmar
    Krippl, Peter
    Voskova, Daniela
    Rossmann, Dieter H.
    Schlick, Konstantin
    Thaler, Josef
    Halter, Britta
    Machherndl-Spandl, Sigrid
    Theiler, Georg
    Valent, Peter
    Eckmuellner, Otto
    Greil, Richard
    [J]. BLOOD, 2014, 124 (21)
  • [44] Venetoclax combined with decitabine or azacitidine in treatment-naive, elderly patients with acute myeloid leukemia
    DiNardo, Courtney D.
    Pratz, Keith
    Pullarkat, Vinod
    Jonas, Brian A.
    Arellano, Martha
    Becker, Pamela S.
    Frankfurt, Olga
    Konopleva, Marina
    Wei, Andrew H.
    Kantarjian, Hagop M.
    Xu, Tu
    Hong, Wan-Jen
    Chyla, Brenda
    Potluri, Jalaja
    Pollyea, Daniel A.
    Letai, Anthony
    [J]. BLOOD, 2019, 133 (01) : 7 - 17
  • [45] Phase 1 Results of Novel Combination Therapy: BET Inhibitor PLX51107 with Azacitidine in Patients with Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Pemmaraju, Naveen
    Bhalla, Kapil N.
    Daver, Naval
    Wilson, Nathaniel R.
    Fiskus, Warren C.
    Ravandi, Farhad
    Garcia-Manero, Guillermo
    Kadia, Tapan M.
    DiNardo, Courtney D.
    Jabbour, Elias J.
    Burger, Jan A.
    Short, Nicholas J.
    Alvarado, Yesid
    Jain, Nitin
    Masarova, Lucia
    Verstovsek, Srdan
    Issa, Ghayas C.
    Qiao, Wei
    Khoury, Joseph D.
    Pierce, Sherry A.
    Miller, Darla
    Konopleva, Marina
    Kantarjian, Hagop
    Borthakur, Gautam
    [J]. BLOOD, 2021, 138
  • [46] HEXAMETHYLENE BISACETAMIDE (HMBA) IN MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID-LEUKEMIA (AML)
    ANDREEFF, M
    STONE, R
    YOUNG, C
    TONG, W
    ERVIN, T
    TAFURI, A
    KOLITZ, J
    RIFKIND, R
    KUFE, D
    MARKS, P
    [J]. LEUKEMIA, 1991, 5 (02) : 174 - 174
  • [47] Acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS) following a diagnosis of breast cancer
    Padmanabhan, A.
    Block, A.
    Sait, S.
    Ford, L. A.
    O'Connor, T. L.
    Moysich, K. B.
    Baer, M. R.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [48] Distinction of Early and Late Molecular Events In Patients with Myelodysplastic Syndromes (MDS) Who Progressed to Acute Myeloid Leukemia (AML)
    Afable, Manuel G., II
    Makishima, Hideki
    Sakaguchi, Hirotoshi
    Jerez, Andres
    Jankowska, Anna Malgorzata
    Guinta, Kathryn M.
    Abu Kar, Sara
    Traina, Fabiola
    Sugimoto, Yuka
    O'Keefe, Christine
    Tiu, Ramon V.
    Sekers, Mikkael A.
    Maciejewski, Jaroslaw P.
    [J]. BLOOD, 2011, 118 (21) : 1522 - 1523
  • [49] Phase 1 study of CWP232291 in relapsed/refractory acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS).
    Cortes, Jorge E.
    Faderl, Stefan
    Pagel, John
    Jung, Chul Won
    Yoon, Sung-Soo
    Koh, Youngil
    Pardanani, Animesh Dev
    Hauptschein, Robert S.
    Lee, Kyoung-June
    Lee, Je-Hwan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [50] Venetoclax and Azacitidine in the Treatment of Patients with Relapsed/Refractory Myelodysplastic Syndrome
    Zeidan, Amer M.
    Borate, Uma
    Pollyea, Daniel A.
    Brunner, Andrew M.
    Roncolato, Fernando
    Garcia, Jacqueline S.
    Filshie, Robin J.
    Odenike, Olatoyosi
    Watson, Anne-Marie
    Krishnadasan, Ravi
    Bajel, Ashish
    Naqvi, Kiran
    Zha, Jiuhong
    Hogdal, Leah
    Zhou, Ying
    Hoffman, David
    Kye, Steve
    Garcia-Manero, Guillermo
    [J]. BLOOD, 2021, 138
12345